Most types of normal cells require integrin-mediated attachment to extracellular matrix to be able to respond to growth factor stimulation for proliferation and survival. Therefore, a consensus that integrins are close collaborators with growth factors in signal transduction has gradually emerged. Some integrins and growth factor receptors appear to be normally in relatively close proximity, which can be induced to form complexes upon cell adhesion or growth factor stimulation. Moreover, since integrins and growth factor receptors share many common elements in their signaling pathways, it is clear tzhat there are many opportunities for integrin signals to modulate growth factor signals and vice versa. Increasing evidence indicates that integrins can crosstalk with receptor tyrosine kinases in a cell-and integrin-type-dependent manner through a variety of specific mechanisms. This review is intended specifically for summarizing recent progress uncovering how the hepatocyte growth factor receptor c-Met coordinates with integrins to transmit signals.
Introduction
Cell adhesion to extracellular matrix (ECM) is a prerequisite for cell proliferation and survival [1] . The effects of ECM on cells are mainly mediated by the integrins, a large family of cell surface receptors that bind to ECM components, organize the cytoskeleton, and activate intracellular signaling pathways. Each integrin is composed of two subunits: a and b. In mammals, 18 a and 8 b subunits associate in various combinations to form 24 integrins that can bind to distinct, although partially overlapping, subsets of ECM proteins [2, 3] . Several lines of evidence indicate that pathways for integrin signaling and growth factor signaling are mechanistically linked. First, cell adhesion to ECM is required for cells to respond to certain growth factors [1] . Second, integrin-mediated cell adhesion and motility can be modulated by growth factors [4] [5] [6] . Third, many of the signaling molecules associated with growth factor receptors, such as Src, are also present in integrin complexes at focal adhesions [7] . Actually, many previous studies suggested that integrins can crosstalk with receptor tyrosine kinases in a cell-and integrintype-dependent manner through a variety of specific mechanisms [8, 9] .
Most integrins activate focal adhesion kinase (FAK) which transduces signals to the downstream through its interaction with several intracellular signaling molecules, including the Src family kinases, PI3K, phospholipase C-c1, Grb2, p130
Cas , and paxillin [10, 11] . FAK is well known for its pivotal role in the control of integrinmediated cell functions, including cell migration, cell cycle progression, and cell survival. However, increasing evidence has also suggested that FAK may be a point of convergence of integrin and growth factor signaling pathways. In addition to cell adhesion, a number of growth factors were shown to stimulate the tyrosine phosphorylation of FAK [12] [13] [14] through activation of the Src family kinases [14] and/or physical association of FAK with the growth factor receptors [15] . The phosphorylation and activation of FAK in response to growth factor stimulation facilitate its association with other signaling molecules, thereby leading to amplification of downstream signals [14, 15] .
Hepatocyte growth factor (HGF), also known as scatter factor, is a mesenchymally derived factor that elicits multiple cellular responses, including proliferation, migration, and morphogenesis, on various types of cells, [16] [17] [18] . The diverse biological effects of HGF are transmitted through activation of its transmembrane receptor encoded by the c-met proto-oncogene [19] . The Met receptor is a heterodimer composed of a 45-kDa a chain that remains entirely extracellular, and a 145-kDa b chain that traverses the plasma membrane and contains the intracellular tyrosine kinase domain [20, 21] . Upon HGF binding, the intrinsic tyrosine kinase of the receptor is activated resulting in autophosphorylation on specific tyrosine residues in the b chain [22, 23] . Two tyrosine residues in the COOH-terminus of the b chain (Tyr-1349 and Tyr-1356) are required for all biological activities of the receptor [24, 25] and serve as docking sites for the Grb2-associated binder-1 (Gab1) docking protein [26, 27] and multiple Src homology 2 and phosphotyrosine binding domain-containing proteins [28, 29] . In human cancers, the c-met gene has frequently been found to be amplified, mutated or overexpressed [17, 18] .
Recent studies indicated that HGF signaling can crosstalk with integrin signaling through at least three modes. First, the Met receptor physically associates with integrins at the plasma membrane where they reciprocally regulate each other. Second, HGF and integrin signaling pathways are converged to some intracellular signaling molecules, such as FAK and Src, which further transduce signals to the downstream. Thirdly, HGF signaling leads to alteration in the expression of integrins that is essential for the biological activities of HGF.
Met-integrin interplay at the plasma membrane
The HGF receptor c-Met engages in reciprocal regulation with integrins at the plasma membrane ( Figure 1 ). The a6b4 integrin has been shown to cooperate with the function of HGF and its receptor c-Met in carcinoma cells, resulting in enhanced invasive growth [30] . Upon c-Met activation, a6b4 integrin physically associates with c-Met and undergoes tyrosine phosphorylation on the b4 cytoplasmic domain, which subsequently forms a complex with Shc and PI3K, thereby potentiating Ras and PI3K signaling ( Figure 1a) . The a6b4 integrin is somewhat special among other integrins in that the b4 subunit contains an unusually long cytoplasmic domain, which provides this integrin with additional Shc binding sites to the Met-a6b4 receptor complex, thereby amplifying Met signaling above a critical threshold for invasive behavior. The extracellular domain of the b4 integrin is not required for its cooperation with the activated c-Met, suggesting an adhesionindependent role for this integrin. In addition, the a6b4 integrin also associates with the epidermal growth factor (EGF) receptor family member ErbB2 in carcinoma cells [31] . Again, the b4 cytoplasmic domain as a monomer is necessary and sufficient to associate with ErbB2, whereas the extracellular domain, and hence matrix binding, is not required for this function [32] .
Integrins, on the other hand, can induce various growth factor receptors to undergo ligand-independent activation, at least to the extent of enhanced tyrosine phosphorylation after cell adhesion [33] [34] [35] [36] [37] . It has been shown that the majority of c-Met in certain tumor cells can be activated by cell attachment, presumably through integrins, in the complete absence of HGF [34] (Figure 1b) . Overexpression of c-Met appears to be a prerequisite for its activation by cell adhesion. Neither the integrity of the actin cytoskeleton nor FAK activation is required for this form of c-Met activation [34] . Moreover, overexpression of c-Met in hepatocytes of mice enables ligand-independent activation of the receptor that leads to hepatocellular carcinoma [38] . However, integrin specificity and the mechanism responsible for the ligandindependent activation of c-Met remain unclear. A previous study done by Moro et al. [39] provides a possible explanation for how integrin-mediated adhesion could induce phosphorylation of growth factor receptors. They found that upon cell adhesion, avb3 and b1 integrins associate with EGF receptors in a complex with p130Cas and c-Src, both of which are crucial for integrin-induced phosphorylation of EGF receptors. Notably, the pattern of EGF receptor phosphorylation induced by integrins is unique, compared to the pattern after EGF-induced autophosphorylation. They found that tyrosine 1148 is unphosphorylated, a key residue that is normally phosphorylated after EGF stimulation. However, four other tyrosines are phosphorylated normally [39] .
Intracellular signaling, called ''inside-out'' signaling, controls the interaction between integrins and ligands [5, 6] . This cell type-specific process modulates integrin affinity, which is caused by a conformational change and modulation of lateral diffusion and/or integrin clustering. HGF has been shown to activate integrin avb3 in epithelial cells [40] , avb3 and a5b1 in endothelial cells [41] , LFA-1 (aM b2) in colon cancer cells and neutrophils [42, 43] , and a4b1 in B cells [44, 45] . In contrast, HGF was reported to inhibit a IIb b3 activation in platelet cells [46] . Nevertheless, the mechanisms underlying those phenomena are unclear.
FAK serves as a point of convergence of HGF and integrin signaling pathways in the cytoplasm
Although a number of growth factors are known to modulate cell motility, HGF is unique because of the intensity with which it stimulates cell motility and induces epithelial-mesenchymal transition. Since FAK is well known for its pivotal role in regulating integrin-mediated cell motility [11] , it was reasonable to speculate that FAK is involved in HGF signaling and plays a role in HGFstimulated cell motility. It is now known that HGF rapidly induces an increase in FAK phosphorylation through at least two mechanisms: one is indirectly mediated by Src [14] and the other is directly phosphorylated by c-Met (Figure 2a) . The maximal activation of FAK upon HGF stimulation may be reached only when both Met-FAK and Met-Src-FAK pathways are activated. The activated FAK functions as a signaling platform to potentiate HGF-elicited signals, thereby contributing to HGF-stimulated cell motility [47] and cell invasion [48] . In accordance with the observation that increased level of FAK contributes to a more aggressive phenotype in tumors [49] [50] [51] , overexpression of FAK renders cultured epithelial cells susceptible to cellular transformation by HGF stimulation [48] . Recently, we found that FAK directly interacts with phosphorylated c-Met upon HGF stimulation. Under certain circumstances, for example, when c-Met is overexpressed and/or constitutively activated, Met-FAK interaction could become constitutive independently of HGF stimulation. This interaction occurs through the band 4.1 and ezrin/radixin/moesin homology domain (FERM domain) of FAK and the phosphorylated Tyr-1349 and Tyr-1356 of c-Met. Notably, the ability of FAK to promote HGFstimulated cell invasion largely depends on its direct interaction with Met.
The immediate response of FAK to HGF stimulation occurs in close proximity to c-Met as described above, which is independent of integrinmediated cell adhesion [14] . Since HGF is known to selectively increase the expression of certain integrins such as integrin a2 and a3 [47, 52, 53] , it is plausible that increased levels of integrins may further lead to the activation of FAK following cell adhesion to ECM proteins. It is therefore likely that the effect of HGF on FAK activation can be through an immediate (integrin-independent) response and a delayed (integrin-dependent) response (Figure 2b) . The sustained activations of FAK and other signaling molecules such as ERK (see below) are critical for the long-term cellular responses to HGF. For instance, the scatter response of Madin-Darby canine kidney (MDCK) cells to HGF stimulation is a dynamic process usually initiated by membrane ruffling and centrifugal spreading of cell colonies (after 1-3 h). Subsequently, some cells within the colony begin to detach from their neighboring cells (after 3-6 h) and exhibit a shape resembling that of motile fibroblasts. These cells continue to migrate (from 6 h), finally leading to a ''scatter'' phenomenon [47] .
HGF induces the expression of integrins via sustained activation of ERK
Although the role of ERK (extracellular signalregulated kinase) singling pathway in cell proliferation has been well established [54] , increasing evidence suggests that the duration of ERK activation may be a crucial determinant for cells to proceed certain cellular functions other than proliferation [55] . For example, in phaeochromocytoma PC12 cells, sustained, but not transient, activation of ERK precedes differentiation into sympathetic-like neurons [56] . Likewise, HGF has been reported to induce sustained activation of ERK [52, [57] [58] [59] . In MDCK cells, sustained activation (at least for 12 h) of ERK is required for HGF to induce cell scattering [52, 58] . In contrast, EGF induces transient activation of ERK in MDCK cells, which declines by 30 min and returns to the basal level by 1 h post stimulation. Whereas HGF induces scatter response of MDCK cells, EGF only induces lamellipodium formation around the cell colony and fails to trigger cell scattering (Figure 3a) . The sustained activation of ERK induced by HGF coincides with its persistent nuclear accumulation, which results in the expression of several genes such as integrins a2 and a3 and matrix metalloproteinase-9 [52, 58] . The inductions of integrin a2b1 and metalloproteinase-9 are required for HGF-induced cell scattering [52, 58] . In addition, the up-regulations of integrins a2b1 and a3b1 are important for HGF-induced branching tubulogenesis in threedimensional collagen gels [53, 60, 61] .
The increased expression of integrin a2 by HGF is a consequence of increased integrin a2 mRNA likely due to transcriptional activation [52] . Characterization of the 5¢-flanking region of human integrin a2 gene reveals that the promoter region contains consensus binding sites for several transcription factors, including Sp1, AP1, and AP2 [62] . The binding of phosphorylated Sp1 to two Sp1 binding sites in the core promoter region of human integrin a2 gene is required for full promoter activity [63] . It is known that ERK activation increases AP1 activity via c-Jun activa- tion and increased c-Fos synthesis, leading to an increase in c-Jun/c-Fos heterodimerization and DNA binding [64, 65] . In addition, ERK can phosphorylate Sp1 and induce its DNA binding activity [66] . Therefore, it is possible that persistent nuclear accumulation of ERK induced by HGF stimulation may target Sp1 and AP1, leading to activation of integrin a2 gene.
The mechanism by which HGF induces sustained activation of ERK and its persistent nuclear retention is unclear. Since integrin-mediated cell adhesion to ECM proteins activates the ERK signaling pathway and often potentiates the effect of growth factors on activating the pathway [67] , the de novo expression of integrins induced by HGF may contribute to the sustained phase of ERK activation (Figure 3b ). It was proposed that prolonged phosphorylation of the major Met-docking protein Gab1 and its association with the tyrosine phosphatase SHP-2 are required for sustained activation of ERK and for epithelial morphogenesis downstream from c-Met [59] . Overexpression of FAK and, presumably, its interaction with Met potentiates the duration of ERK activation [48] . Moreover, York et al. [56] showed that in PC12 cells, the early phase of nerve growth factorstimulated ERK activation is mediated by the small GTPase Ras, but the sustained phase of the ERK activation is due to activation of another small GTPase, Rap1. The role of Rap1 in HGFinduced sustained activation of ERK remains to be clarified. It was reported that the immediate early gene product c-Fos functions as a sensor for ERK signal duration [68] . When ERK activation is transient, its activity declines before the c-Fos protein accumulates, and under such condition c-Fos is unstable. However, when ERK signaling is sustained, it persistently accumulates in the nucleus and phosphorylates c-Fos. Carboxyterminal phosphorylation stabilizes c-Fos and primes additional phosphorylation by exposing a binding site for ERK, termed the DEF domain. Interestingly, putative DEF domains are also found in other AP-1 proteins, such as Fra-1, Fra-2, JunB, and JunD [68] . It has been shown that HGF induces increased and prolonged expression of c-Fos [58] . It remains to be determined whether the interaction of ERK with c-Fos or other DEF domain-containing proteins in the nucleus is essential for its persistent nuclear retention.
Perspectives
There has been substantial recent progress in understanding how integrin and the c-Met receptor collaborate to transmit signals and thereby coordinate regulate cell behavior. The picture emerging from these studies is that the crosstalk networks between signaling pathways from both types of cell surface receptors are intertwined at various cellular locations through various modes.
Nonetheless, several open questions remain to be answered. At the plasma membrane, it will be important to determine which types of integrins are involved in ligand-independent activation of c-Met and the underlying mechanism for the activation. In the cytoplasm, some molecules, e.g. FAK, are engaged in both integrin and HGF signaling pathways. Does integrin compete with c-Met for FAK? Do signals propagated by reciprocal regulation between Met and FAK produce unique biological effects? In the nucleus, it will be important to determine the mechanism by which HGF induces persistent nuclear retention of ERK. What are the targets of transient vs. sustained activation of ERK? Understanding these circuits in detail should shed light on a variety of pathological states as well as delineate more effective strategies for future therapeutic intervention.
